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Abstract At the 93rd annual meeting of the Physiological
Society of Japan, a symposium entitled ‘‘Expanding fron-
tiers in weight-control research explored by young inves-
tigators’’ was organized. The latest research on weight
control was presented by young up-and-coming investiga-
tors. The symposium consisted of the following presenta-
tions: Gastrointestinal brush cells, immunity, and energy
homeostasis; Impact of a brown rice-derived bioactive
product on feeding regulation and fuel metabolism; A
novel G protein-coupled receptor-regulated neuronal sig-
naling pathway triggers sustained orexigenic effects; and
NMDA receptor co-agonist D-serine regulates food pref-
erence. These four talks presented at the symposium were
summarized as a series of short reviews in this review.
Keywords Type 2 immune response  c-Oryzanol 
Appetite  DREADD  Anorexia
Main text
Gastrointestinal brush cells, immunity, and energy
homeostasis (by Yoshiro Ishimaru)
The intestinal epithelium has at least two critical functions:
absorption of nutrients and defense against pathogens and
parasites. There are four major cell types in the small
intestine: enterocytes, Goblet, Paneth, and enteroendocrine
cells [1]. Enterocytes absorb nutrients, water, and elec-
trolytes, whereas Goblet, Paneth, and enteroendocrine cells
secrete mucus, peptides that provide defense against
microbes, and gastrointestinal hormones that regulate
intestinal function and communication with other organs.
In addition to these cell types, brush cells (also referred to
as tuft cells or caveolated cells) constitute a minor fraction
(0.4 %) of the adult mouse intestinal epithelium [2, 3], and
they are also found in the trachea, salivary glands, and
stomach. Brush cells are characterized by their unique
morphology, with an extensively developed cytoplasmic
tubulovesicular system and an apical bundle of microfila-
ments connected to a tuft of long and thick microvilli
projecting into the lumen [4]. These cells express transient
receptor potential melastatin 5 (Trpm5), doublecortin-like
kinase 1 (Dclk1), and choline acetyltransferase [2, 5–8].
Although brush cells were discovered more than 50 years
ago [9], the mechanisms of differentiation and the function
of these cells have remained elusive.
The Skn-1 (also known as Pou2f3) gene, which encodes
the POU homeodomain transcription factor, was originally
identified as a regulator of the differentiation of epidermal
keratinocytes [10, 11]. Subsequently, it was reported that
Skn-1a is also expressed in sweet, umami (savory), and
bitter-sensing taste cells (referred to as type II taste cells) in
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respiratory epithelium, and in microvillus cells in the main
olfactory epithelium and is required for the differentiation
of these types of Trpm5-expressing cells [12–14]. Recently,
we and another group demonstrated that neither Dclk1 nor
Trpm5 is expressed in the gastrointestinal (GI) tract of Skn-
1 knockout (KO) mice [15, 16]. These results demonstrate
that brush cells are completely abolished in Skn-1 KO mice
and that Skn-1a is a crucial transcription factor for gener-
ating brush cells in the GI tract.
To examine the effect on energy homeostasis of elimi-
nating type II taste cells and brush cells in the GI tract, we
characterized the metabolic phenotypes of Skn-1 KO mice
[16]. Despite unaltered food intake, Skn-1 KO mice have
reduced body weight with lower body fat due to increased
energy expenditure. In this model, 24-h urinary excretion
of catecholamines was significantly elevated, accompanied
by increased fatty acid oxidation and fuel dissipation in
skeletal muscle and impaired insulin secretion driven by
glucose. These results suggest the existence of novel brain-
mediated energy homeostatic pathways that originate from
brush cells and type II taste cells in the GI tract and end in
the peripheral tissues, including the adrenal glands (Fig. 1).
Parasitic infections, caused by intestinal helminths and
protozoan parasites, are the most common infections in
humans living in developing countries. Helminth and
protozoan parasitic infections, as well as allergens, induce
a type 2 immune response that involves a remodeling of the
epithelial cell populations, including Goblet cell hyper-
plasia. Interleukin (IL)-13 is crucial for this response and is
secreted by type 2 innate lymphoid cells (ILC2s) and type 2
helper T cells (TH2 cells) [17]. ILC2s are thought to be
major initiators of type 2 immune responses after parasitic
infections. The epithelial cytokines IL-33, thymic stromal
lymphopoietin (TSLP), and IL-25 are required for the
activation of ILC2s [18, 19]. Although it was assumed that
the secretion of cytokines by the intestinal cells is required
for type 2 immune responses following parasitic infections,
it has remained elusive which types of intestinal cells ini-
tiate these responses.
Recent studies have independently reported that brush
cells play a pivotal role in the initiation of type 2 immune
responses [15, 20, 21]. As already mentioned, the brush
cells expressing Dclk1 and Trpm5 constitute only a small
population of the adult mouse intestinal epithelial cells




















Fig. 1 Schematic representation of the presumed metabolic pathways
originating from brush cells and type II taste cells in the GI tract.
Food components and digested nutrients are detected by the tongue
and GI tract. In Skn-1 KO mice, the lack of type II taste cells and
brush cells results in increased catecholamine secretion. Lipolysis in
WAT, serum levels of total ketone bodies, and thermogenesis in
muscle are increased, whereas insulin secretion from the pancreas is
reduced. Consequently, Skn-1 KO mice have reduced body weight
with lower body fat percentage due to higher energy expenditure. In
addition, brush cells play a pivotal role in the initiation of type 2
immune responses induced by helminth and protozoan parasitic
infections. Portions of this figure were modified from Fig. 6 in
Ushiama et al. [16]
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secreting cells, von Moltke and colleagues showed that the
cells expressing IL-25 are brush cells [21]. However, brush
cells did not produce other epithelial cytokines activating
ILC2s, including IL-33 or TSLP [21]. After helminth or
protozoan infections, a hyperplasia of brush cells and
Goblet cells was observed [15, 20, 21]. In addition, Howitt
and colleagues reported that wild-type specific-pathogen-
free mice that were bred in their facility had a larger
number of brush cells than in previous reports [20]. A
series of experiments using a variety of knockout or
transgenic mouse strains revealed that a hyperplasia of
brush cells, as well as that of Goblet cells, was dependent
on IL-13 signaling produced by ILC2s. When infected with
helminth, helminth expulsion was delayed in Skn-1 KO
mice that lack brush cells compared to wild-type mice.
Trpm5 and alpha-gustducin, which encode signal trans-
duction molecules downstream of sweet, bitter, and umami
taste receptors, are also expressed in brush cells [5].
Intriguingly, brush cell hyperplasia did not occur in Trpm5
or alpha-gustducin KO mice [20]. In summary, brush cells
are the sole source of IL-25 in the steady state. After hel-
minth infection, IL-25 secreted by brush cells activates
ILC2s, resulting in IL-13 production. IL-13 acts on
intestinal stem cells and promotes the differentiation of
brush cells and Goblet cells. Brush-cell hyperplasia further
increases IL-25 expression and subsequent IL-13 secretion
by ILC2s in a feed-forward loop.
Further studies are needed to answer the following
questions: How do brush cells (which types of G protein-
coupled receptors) detect intestinal parasites? Do brush
cells have different roles from type 2 immune responses?
What is the relationship between type 2 immune responses
and energy homeostasis? The discovery of food-derived
factors that regulate brush cells may open new avenues for
the treatment of allergic diseases, obesity, and diabetes.
Impact of a brown rice-derived bioactive product
on feeding regulation and fuel metabolism (by
Chisayo Kozuka)
Anti-obesity and anti-diabetic components of brown
rice
Previous studies have shown that a diet containing whole
grains such as brown rice improves glucose metabolism
compared with refined-grain diets [22, 23]. A previous
clinical study of ours showed that brown rice significantly
decreased body weight and ameliorated glucose and lipid
dysmetabolism compared with white rice in subjects with
metabolic syndrome [24]. During the refining process, most
of the outer parts of the grain are removed despite their
containing multiple nutrients. Dietary fiber is thought to
play a pivotal role in the metabolically beneficial effects of
whole grain foods. For instance, some types of fiber such as
arabinoxylan and b-glucan are growth substrates for the
beneficial bacteria Bifidobacterium and Lactobacillus
[25, 26]. A previous study has shown that brown rice
beneficially alters the composition of gut microbiota in
humans [27]. These data suggest that brown rice amelio-
rates obesity and diabetes at least partly via its effect on the
profile and activity of intestinal microbiota. Conversely,
brown-rice-derived fiber has been shown to have no effect
on body weight or glucose metabolism in either healthy or
diabetic rats [22]. This result suggests that brown rice
contains anti-obesity and anti-diabetic components other
than dietary fiber. c-oryzanol is a brown rice-specific
bioactive component that is a mixture of ferulic acid esters
and phytosterols such as cycloartenol, b-sitosterol,
24-methylenecycloartenol, and campesterol [7]. After oral
administration, c-oryzanol is mainly distributed in the
brain, and is metabolized in the liver [28–30]. Previous
studies have shown various beneficial effects of c-oryzanol
including cholesterol-lowering, anti-inflammatory, anti-
cancer, anti-diabetic, and anti-oxidant activities [31].
Membrane permeability is correlated with lipophilicity,
usually estimated using the logarithm of the n-octanol/
water partition coefficient (log Po/w) [32]. The log Po/w of
c-oryzanol has been calculated as 12.1 using the XLOGP3
method [33], while that of fenofibrate, one of the most
lipophilic agents among the clinically-used drugs, is 5.19
[34, 35]. This suggests that c-oryzanol should be lipophilic
enough to be membrane permeable and thus may influence
intracellular metabolism. In our animal study, we demon-
strated that brown rice and c-oryzanol attenuate the pref-
erence for dietary fat and consequently decrease body
weight gain [36].
Feeding regulation and obesity
Feeding behavior is regulated by the hypothalamus and
mesolimbic reward system. The hypothalamic arcuate
nucleus plays a key role in energy homeostasis and regu-
lates food intake, energy expenditure, and body weight
[37]. Leptin, an adipocyte-derived hormone, suppresses the
appetite and increases energy expenditure through its
action on the hypothalamus [38]. In obese subjects, exag-
geration of inflammatory signals and endoplasmic reticu-
lum (ER) stress induce leptin resistance in the
hypothalamus and consequent hyperphagia [39–41]. Of
note, we have previously shown that hypothalamic ER
stress increases the preference for dietary fat [36]. When
mice were allowed to choose freely between a chow and a
high-fat diet (HFD), they strongly preferred the HFD. In
contrast, in mice treated with 4-phenylbutyric acid, an ER
stress reducer, the HFD preference was significantly
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decreased. These data suggest the importance of hypotha-
lamic inflammation and ER stress as novel therapeutic
targets for obesity. In an in vitro reporter assay in HEK293
cells, c-oryzanol significantly suppressed an ER stress
inducer, tunicamycin-induced activation of cis-acting ele-
ments such as ER stress response elements and an unfolded
protein response element [36]. Therefore, we examined the
possibility that brown rice and c-oryzanol could ameliorate
dysregulation of feeding. In HFD-fed mice, oral adminis-
tration of brown rice or c-oryzanol significantly decreased
ER stress and inflammation in the hypothalamus [36]
(Fig. 2). As expected, preference for the HFD was signif-
icantly decreased in mice treated with brown rice or c-
oryzanol [36] (Fig. 2).
Recent studies have also shown the importance of the
reward system in feeding regulation [42, 43]. The reward
system plays an essential role in addiction to palat-
able foods, which shares mechanisms with drug addiction
[44]. Dopamine receptor signaling is a key component of
the brain’s reward system. Dopamine release in the dorsal
striatum induced by feeding is related to pleasure [45].
Reduced dopamine D2 receptor (D2R) densities in the
dorsal striatum of obese humans and rodents renders them
less responsive to food rewards compared with lean con-
trols [46–48]. In humans, reduction of striatal D2R
expression by the TaqIA allele of the DRD2/Ankyrin
repeat and kinase domain containing 1 (ANKK1) gene
locus is associated with obesity [49], while effects of
weight loss after bariatric surgery are associated with ele-
vated striatal D2R density [50]. Knockdown of striatal D2R
by lentivirus-mediated short hairpin RNA rapidly induced
addiction-like reward deficits and compulsion-like food
seeking in rats [48]. In this context, we hypothesized that
brown rice and c-oryzanol would attenuate the preference
for dietary fat at least partly through effects on D2R sig-
naling. As expected, expression levels of striatal D2R were
significantly decreased in HFD-fed mice, while c-oryzanol
restored the expression levels (Kozuka et al. manuscript
under review) (Fig. 2). Anti-obesity drugs acting on the
brain reward system (e.g., rimonabant) have been devel-
oped, but most were withdrawn from clinics because of
considerable adverse effects including serious psychiatric
problems [51]. Natural food-derived products such as c-
oryzanol may be an alternative treatment to safely regulate
feeding behavior.
D2R signaling in pancreatic islets
Recent studies have shown that molecules involved in
dopamine receptor signaling are expressed not only in the
brain but also in both murine and human pancreatic islets
[52, 53]. In patients with Parkinson’s disease, treatment
with L-DOPA, a dopamine precursor, significantly impairs
glucose metabolism in a dose-dependent manner [54, 55].
In mice, D2R are confined to b-cells [52], and knockout of
D2R suppresses function and replication of pancreatic b-
cells during development [56]. Of note, in isolated pan-
creatic islets from humans, treatment with dopamine
attenuates insulin via its receptors [53]. Thus, we investi-
gated the possibility that brown rice and c-oryzanol could
ameliorate glucose dysmetabolism in HFD-fed mice via
local D2R signaling in islets (Fig. 3). Insulin secretion
from b-cells is mainly regulated by two distinct signaling
pathways: (1) the ATP-sensitive K? channel-dependent
pathway (triggering pathway) or (2) the cAMP/PKA
pathway (amplifying pathway) [57, 58] (Fig. 3). D2R sig-
naling decreases intracellular cAMP levels in pancreatic
islets as well as in the striatum and pituitary gland [59–61],
and consequently decreases glucose-stimulated insulin
secretion by suppressing the amplifying pathway [61]. Of
note, expression levels of D2R signaling molecules were
increased in islets of HFD-fed mice, and decreased with
oral administration of c-oryzanol [61]. Because c-oryzanol
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Fig. 3 c-oryzanol enhances GSIS via the inhibition of D2R
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pancreatic islets [28], c-oryzanol may decrease expression
levels of D2R signaling molecules via the consensus ele-
ments of NF-jB in the promoter region of Drd2 [62].
Interestingly, there were no agonist or antagonist activities
of c-oryzanol on dopamine receptors [28]. A previous
study in rats suggests that c-oryzanol may have effects on
dopamine metabolism in the medial basal hypothalamus
[63]. These findings suggest that c-oryzanol has effects on
local dopamine synthesis. Although further studies are
necessary to fully elucidate the molecular mechanisms
involved, c-oryzanol shows potential as a treatment for
obesity and diabetes.
A novel G protein-coupled receptor-regulated
neuronal signaling pathway triggers sustained
orexigenic effects (by Kenichiro Nakajima)
Introduction
Obesity has emerged as one of the most severe health
problems in the world [64]. Obesity represents a major risk
factor for metabolic syndrome and is associated with type 2
diabetes, cancer, and cardiovascular disease. The current
obesity epidemic significantly affects public health and
reduces economic activity by increasing medical costs.
Owing to the low success rate of long-lasting weight loss
from dietary changes and physical activity, there is a strong
need for effective pharmacological strategies to stop obe-
sity [65]. Unfortunately, the number and efficacy of
appetite-suppressing drugs approved for clinical use is
severely limited [65].
To develop novel appetite-suppressing drugs, it is
essential to understand the neuronal circuits that regulate
food intake in the brain. In this chapter, we focus on a
small subpopulation of hypothalamic neurons located in
the arcuate nucleus (ARC) of the hypothalamus, which
synthesize and release agouti-related peptide (AgRP), a
neuropeptide endowed with potent, long-lasting orexigenic
activity [66]. These neurons, which are generally referred
to as AgRP neurons, secrete two additional chemicals that
promote acute feeding, neuropeptide Y (NPY) and GABA,
a biogenic amine neurotransmitter [66, 67]. These three
orexigenic agents have different sizes and effects, and, at
present, their relative roles in stimulating appetite in
response to different hormones or neurotransmitters are not
well understood.
As indicated by the fact that AgRP neurons are next to
the third ventricle and sense nutrients and hormones
derived from peripheral organs, numerous studies have
shown that AgRP neurons play a key role in regulating
food intake and energy homeostasis [68–71]. In the past
5 years, novel toolkits in the field of neuroscience,
including optogenetics and chemogenetics [72] (Fig. 4),
have shown that activation of AgRP neurons leads to an
acute feeding response [73, 74]. In contrast, genetic abla-
tion of AgRP neurons in adult mice leads to a loss of
appetite, and ultimately starvation [75]. This novel evi-
dence emphasizes that AgRP neurons play a role in driving
appetite.
Use of designer G protein-coupled receptors
to dissect orexigenic signaling pathways in AgRP
neurons
As in the case of other cell types, the activity of AgRP
neurons is regulated by cell-surface receptors belonging to
the superfamily of G protein-coupled receptors (GPCRs),
which are linked to distinct functional classes of hetero-
trimeric G proteins such as Gaq, Gas, and Gai [76, 77]
(Fig. 4). For example, Gq-coupled receptors can couple
with Gq, which activates phospholipase Cb, leading to an
increase in intracellular calcium ion concentration. In
contrast, Gs-coupled receptors can couple with Gas, which
activates adenylate cyclase, leading to an increase in cAMP
concentrations. In contrast, Gi-coupled receptors can cou-
ple with Gai, which inhibits adenylate cyclase activity,
leading to a decrease in cAMP concentrations. So far, the
functional consequences of activating the various GPCR/G
protein signaling pathways in AgRP neurons have not been
systematically studied. To address this issue, we employed
a new set of pharmacological tools referred to as
DREADDs (designer receptors exclusively activated by
designer drugs, Fig. 4). DREADDs represent mutant
muscarinic acetylcholine receptors that lose the ability to
bind acetylcholine or any other endogenous ligands [78].
However, DREADDs can be selectively activated by
clozapine-N-oxide (CNO), a synthetic compound, which is
otherwise pharmacologically inert [78, 79]. Currently,
there are various types of newly developed DREADDs
with distinct G protein-coupling properties available
[80, 81]. Use of DREADDs makes it possible to monitor
the in vivo consequences of activating distinct GPCR sig-
naling pathways in a drug (CNO)-dependent fashion in
specific cell types. Such studies are not possible to perform
with native GPCRs, which are expressed in various tissues
and cell types in general [82].
We injected Cre-dependent recombinant adeno-associ-
ated virus (AAV) containing Gs-coupled DREADD (GsD;
Fig. 4) or Gq-coupled DREADD (hM3Dq; Fig. 4) to
AgRP-ires-Cre knockin mice by stereotaxic injection. This
generates mice that selectively express hM3Dq (hM3Dq-
AgRP mice) or GsD (GsD-AgRP mice) in the AgRP neu-
rons of the ARC [74, 83]. Food intake studies show that
treatment of GsD-AgRP mice with a single dose of CNO
resulted in an orexigenic effect that lasted for several days
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and was associated with a significant increase in body
weight (Fig. 4, middle). In contrast, the stimulatory effect
observed with CNO-treated hM3Dq-AgRP mice lasted
only for a single day (Fig. 4, left), most likely reflecting
differences in the cellular activity caused by the activation
of Gs- versus Gq-dependent signaling pathways.
AgRP neurons store and release the neuropeptides AgRP
and NPY as well as the biogenic amine, GABA, all of
which promote food intake [66]. Using a combined genetic/
pharmacological approach, we demonstrated that NPY and
GABA release do not contribute to the orexigenic effects
mediated by GsD expressed by AgRP neurons (Fig. 5)
[83]. In contrast, a GsD-mediated increase in food intake
was completely blocked by intracerebroventricular treat-
ment of GsD-AgRP mice with an anti-AgRP antibody [83].
Importantly, such effects were not seen at all in hM3Dq-
AgRP mice. These data clearly indicate that the ability of
Gs-coupled DREADD to promote food intake is mediated
by the release of AgRP (Fig. 5).
Discussion
Some activators of AgRP neurons have already been
revealed. As an excitatory synaptic input, glutamate acti-
vates the N-methyl-D-aspartate receptor, inducing neuronal
excitation [84]. In terms of hormones, the stomach-derived
orexigenic peptide, ghrelin, stimulates Gq-coupled ghrelin
receptors expressed by AgRP neurons to induce acute
feeding as observed in hM3Dq-AgRP mice treated with
CNO (Fig. 5) [74, 76, 83]. By contrast, pituitary adenylate
cyclase activating peptide (PACAP) neurons in the par-
aventricular hypothalamus (PVH) innervate AgRP neurons
that express Gs-coupled PACAP receptors [85, 86] (Fig. 5).
We found that DREADD-mediated activation of PACAP
neurons in the PVH leads to long-lasting food intake,
similar to that observed in GsD-AgRP mice treated with
CNO [83]. This suggests that PACAP is one of the
endogenous activators of AgRP neurons causing long-
lasting orexigenic responses.
Recent studies have shown that when both NPY and
GABA pathways are genetically impaired in AgRP
Gαq Gαs Gαi
[Ca2+] [cAMP] [cAMP]
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precise functions of specific
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the relationship between
signaling pathways in AgRP
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Fig. 5 Different roles of Gq- and Gs-coupled GPCRs expressed by
AgRP neurons in food intake. Gq-coupled GPCRs (e.g., ghrelin
receptors) stimulate the calcium signaling pathway, resulting in an
acute feeding response caused by NPY and GABA release. By
contrast, Gs-coupled GPCRs (e.g., PACAP receptors) stimulate the
cAMP signaling pathway, resulting in long-lasting feeding caused by
AgRP release
88 J Physiol Sci (2017) 67:83–95
123
neurons, activation of Gq-coupled DREADD cannot induce
an acute feeding response [67] (Fig. 5). Combined with
these results, I would like to propose a working hypothesis
concerning the roles of GPCRs in AgRP neurons (Fig. 5).
Gq-coupled GPCRs (e.g., ghrelin receptors) stimulate cal-
cium signaling, resulting in an acute feeding response
caused by NPY and GABA release. By contrast, Gs-cou-
pled GPCRs (e.g., PACAP receptors) stimulate cAMP
signaling, resulting in long-lasting feeding caused by AgRP
release. In the future, it will be necessary to examine when
each signaling pathway is activated under normal and
pathophysiological conditions in AgRP neurons.
Conclusions
Our findings raise the possibility that drugs that block the
activity of Gs-coupled receptors endogenously expressed
by AgRP neurons might become useful as appetite-sup-
pressing drugs. The identification of the complete set of
GPCRs expressed by AgRP neurons under physiological
and pathophysiological conditions should provide a
rational basis for this approach.
NMDA receptor co-agonist D-serine regulates food
preference (by Tsutomu Sasaki)
Introduction
D-serine is an amino acid enantiomer of serine. Although
proteins in mammals are made of the L-form of amino
acids, the D-form of amino acids is present in the body. D-
serine is abundant in the forebrain, and the concentration of
D-serine in the brain correlates with the density of N-
methyl-D-aspartate (NMDA) receptor [87–90]. It serves as
a co-agonist for NMDA receptor and facilitates synaptic
excitatory glutamatergic neurotransmission [91–93]. D-
serine production and degradation are regulated in vivo by
serine racemase (SR) [94–96] and D-amino acid oxidase
[97], respectively. D-serine is also supplied from food, such
as fermented foods, microorganisms, plants, and marine
invertebrates [98]. Based on the level of D-serine present in
the cerebral cortex of SR-knockout mice, it is estimated
that 90 % of brain D-serine is maintained by endogenous
production and 10 % is supplied from the gastrointestinal
tract.
NMDA receptor signaling had been implicated in the
regulation of food intake. Generally speaking, agonists for
NMDA receptors were reported to suppress food intake,
while inhibitors were to promote food intake [99–103].
There are two endogenous co-agonists for NMDA receptor,
D-serine and glycine [91, 92, 104]. The plasma level of
glycine is low in obese subjects [105], whereas it is high in
anorexia nervosa patients [106, 107]. While glycine has its
own cognate glycine receptors that mediate inhibitory
neurotransmission [108] (instead of excitatory neurotrans-
mission expected through NMDA receptor), and has mul-
tiple modes of biological actions outside of the nervous
system, co-agonism of NMDA receptor is the only known
in vivo function of D-serine [109]. Therefore, our group
analyzed the effect of D-serine on feeding behavior in mice.
Results
We first tested the effects of ad libitum drinking of D-serine
water on food intake in male mice. The varying concen-
tration of D-serine water was provided to mice fed either a
normal chow diet or a high-fat diet. We found that the
increasing dose of D-serine in the drinking water signifi-
cantly suppressed the intake of high-fat diet, but not the
normal chow diet [110]. D-serine water at 1.5 % (weight/
volume) concentration also suppressed the intake of a high-
sucrose diet and a high-protein diet. The effect was strong
enough that some mice did not eat for 2–3 days.
In order to avoid the starvation-like response, we next
gave choices of food to mice, normal chow diet and either
high-fat diet, high-sucrose diet, or high-protein diet. In the
presence of food choices, ingestion of D-serine reversed the
preference for food in all three diets tested. D-serine altered
food preferences when given simultaneously with food
choices (during the acquisition phase of food preference)
and when it was given after the food preference was
already expressed (during the expressed phase of food
preference). Upon withdrawal of D-serine water, mice re-
gained the original food preference. Affecting both phases
of food preferences indicated that the phenotypes are not
due to food neophobia. Interestingly, the degree of effect D-
serine exerts on food preference correlated with the degree
of original preference for food. D-serine reversed the
preference for food in the order of high-fat diet, high-
protein diet, and high-sucrose diet. To prove that the effect
was dependent on the co-agonism toward the NMDA
receptor, we used L-701,324, the selective and full antag-
onist at the glycine-binding site of the NMDA receptor.
L-701,324 effectively blocked the suppression of a high-fat
diet preference acquisition by D-serine. These data indi-
cated that D-serine regulates food preference through co-
agonism toward the NMDA receptor.
We also analyzed the effect of D-serine on the acquisi-
tion of preference toward high-fat diet over normal chow
diet in capsaicin-treated sensory-deafferented mice [111]
and genetically obese db/db mice [112]. In both situations,
D-serine prevented mice from acquiring the preference
toward a high-fat diet. Interestingly, the sensory-deaffer-
ented control mice, due to the lack of sensory input, took
longer time (4–5 days) to acquire the preference toward a
J Physiol Sci (2017) 67:83–95 89
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high-fat diet, but they did acquire the preference probably
relying on the post-ingestive humoral cues. Conversely, the
sensory-deafferented D-serine mice acquired preference
toward normal chow (instead of a high-fat diet) during the
same time frame. These data indicate that the effect of D-
serine on food preference is not dependent on sensory
neural input (including visceral nervous input conveyed by
vagus nerve) and leptin receptor signaling.
We further performed food preference experiments in
the context of re-feeding after fasting because mice prefer
carbohydrates over fat after fasting [113]. During re-feed-
ing after 24-h fasting, D-serine significantly suppressed the
intake of a normal chow diet but not a high-fat diet for the
first hour, but suppressed the intake of a high-fat diet but
not a normal chow diet by the third hour. These data
indicated that D-serine suppressed the intake of food that
mice find palatable at the time (Fig. 6). We also performed
experiments using intraperitoneal injection of D-serine. The
results are overall consistent with the finding from the oral
D-serine experiments (unpublished data).
Discussion
Animals decide whether to eat and what to eat based on the
integration of peripheral sensory stimuli (such as taste and
smell), internal metabolic and physiological signals that
reflects the body’s needs (such as hormones and nutrients),
motivation, and experience. NMDA receptor signaling
contributes to both the suppression and promotion of food
intake at multiple nodes of appetite, including the solitary
tract nucleus, parabrachial nucleus, ventromedial nucleus
of the hypothalamus, paraventricular nucleus of the
hypothalamus, the lateral habenula, the lateral hypothala-
mic area, and the ventral tegmental area [103, 114–125].
Therefore, D-serine could affect feeding behavior at mul-
tiple aspects. So where does exogenously administered D-
serine work to regulate food preference? Our experimental
data collectively suggest that the main target of D-serine
appear not to be at the level of sensing (both peripheral
sensory stimuli and metabolic signals) or homeostatic
phase, but to be at the hedonic phase controlled by the
central nervous system, possibly altering the post-ingestive
rewarding effect of diet. What is the implication of these
results generated by the administration of pharmacological
dose of D-serine to mice?
The D-serine model recapitulates some of the symptoms
observed in anorexia nervosa (AN), such as the voluntary
reduction in food intake despite unmet metabolic needs
(observed in the 24-h fasting re-feeding experiment),
avoiding foods that are considered palatable in normal
condition, and the restriction of food intake accompanied
by severe weight loss [126]. So hyper-activation of gluta-
matergic signaling through NMDA receptor may be an
underlying risk factor for the pathogenesis of AN. Patients
with AN exhibit abnormal reward circuitry, in both struc-
tural and functional neuroimaging studies [127, 128]. AN is
highly associated with anxiety disorder comorbidities, such
as obsessive–compulsive disorder and social anxiety dis-
order [129]. The mesolimbic mechanisms involved in
hedonic food reward have been postulated to contribute to

















Fig. 6 Summary of D-serine
and food preference data. D-
serine suppressed the intake of
food that mice prefer at the
given moment under 1-food
access and 2-food choices
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the generation of obsessive dreads in addition to obsessive
desires [130, 131]. Both obsessive–compulsive disorder
and AN are associated with increased glutamate levels in
the cerebrospinal fluid [132, 133]. Moreover, serum D-
serine levels were elevated in patients with depression [94],
and the NMDA receptor antagonist ketamine showed rapid
and robust antidepressant effects [134]. Glutamatergic
neurotransmission through NMDA receptor, together with
GABAergic neurotransmission, have been postulated to
regulate the vulnerability to activity-based anorexia [135].
Our data and indirect evidence in the literature were con-
sistent with the hypothesis that hyper-activation of NMDA
receptor signaling within the central nervous system, pos-
sibly within the reward circuitry, may be one among many
factors that contribute to the pathogenesis of AN. Patients
with AN may have altered neurocircuitry, different sensi-
tivities to D-serine, and/or altered D-serine metabolism
(Fig. 7), which might increase their vulnerability to other
factors that contribute to the pathogenesis of the disease,
such as variations in brain-derived neurotrophic factor
(BDNF) and adolescent stress [136]. AN has the highest
mortality rate among all psychiatric disorders [137], and no
randomized controlled treatment trials have demonstrated
efficacy in achieving remission in adult patients with
chronic AN [138]. Considering the high morbidity and the
lack of effective pharmaceutical treatment, we believe that
these hypotheses are worth testing.
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